LINC02634

Across TCGA pan-cancer cohorts, LINC02634 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02634’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02634 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02634 is over-expressed in tumor, although a few such as BRCA and STAD show the opposite, repressed pattern.

KIRC, BRCA, and STAD are the cancer types where LINC02634 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02634 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.116	.010	5	view →
BRCA	Female	All	−0.121	<.001	4	view →
STAD	All	All	−0.111	.009	4	view →
UCEC	All	All	−0.181	.022	2	view →
THCA	Female	All	+0.126	.011	2	view →
LUSC	Male	All	−0.074	.001	2	view →
COAD	Male	II,III,IV	−0.055	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02634–KIRC

Open the KIRC breakdown →